GeneCraft
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $7.6M
Investors
- 3
About GeneCraft
Based in Cheongju, South Korea, and founded in 2020, GeneCraft operates as a biotechnology company with research exchange centers conducting gene theraphy. The pre-clinical-stage biotech company offers gene therapy, for treatment outcomes of incurable diseases by leveraging the innate oncogene defense system. GeneCraft’s technical features include programs like RX001, a first-in-class treatment for Pan K-RAS mutated lung cancer. The firm employs the Ubi-AAV Platform to craft gene therapeutics, distinguishing abnormal K-RAS mutated cancer cells and selectively inducing their death.
Who invested in GeneCraft
3 investors across 1 round
See all investors in GeneCraft
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 15, 2024
Amount
$7.6M
Investors
Questions about GeneCraft
Who invested in GeneCraft?
GeneCraft has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GeneCraft raised?
GeneCraft has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GeneCraft last raise money?
GeneCraft's most recent round on record is a Series A, in Jan 2024.
What does GeneCraft do?
Based in Cheongju, South Korea, and founded in 2020, GeneCraft operates as a biotechnology company with research exchange centers conducting gene theraphy.
Where is GeneCraft headquartered?
GeneCraft is headquartered in Cheongju, South Korea.
Which VCs invest in companies like GeneCraft?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GeneCraft's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GeneCraft? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.